Related Experiment Video
Updated: Aug 17, 2026
Translational Orthotopic Models of Glioblastoma Multiforme
Published on: February 17, 2023
Applications of mouse glioma models in preclinical trials
1Department of Cell Biology and Genetics, New York, NY 10021, USA.
Abstract:
Gliomas are the most common primary tumors that arise from glial cells and their precursors in the central nervous system. Most of the genetic alterations identified in human gliomas result in signal transduction abnormalities or disruption of cell cycle arrest pathways. Over the past years, several mouse glioma models have been generated based on human genetic abnormalities and the induced gliomas exhibit histological similarities to their human counterparts. There is emerging evidence suggesting that an oncogenic signaling initiating tumorigenesis is also required for tumor maintenance, these glioma models can be used to further characterize the mechanisms of oncogenic signaling in tumor formation, as well as identify molecular targets in preclinical trials.
Insights
Mouse glioma models mimic human tumors, aiding research into cancer-causing signals and potential treatments. These models help understand oncogenic signaling in glioma development and maintenance.
Area of Science:
- Neuro-oncology
- Cancer Biology
- Genetics
Background:
- Gliomas are primary central nervous system tumors originating from glial cells.
- Genetic alterations in gliomas often disrupt signal transduction and cell cycle arrest pathways.
- Understanding these disruptions is key to developing effective treatments.
Purpose of the Study:
- To review the utility of mouse glioma models in studying human glioma pathogenesis.
- To explore the role of oncogenic signaling in both glioma initiation and maintenance.
- To identify potential molecular targets for preclinical therapeutic trials.
Main Methods:
- Generation of mouse glioma models based on human genetic abnormalities.
- Histological comparison of induced gliomas in mice with human gliomas.
- Analysis of oncogenic signaling pathways in preclinical models.
Main Results:
- Mouse models exhibit histological similarities to human gliomas.
- These models provide a platform to study the mechanisms of oncogenic signaling.
- Emerging evidence supports the role of oncogenic signaling in tumor maintenance.
Conclusions:
- Mouse glioma models are valuable tools for advancing neuro-oncology research.
- Further characterization of oncogenic signaling in these models can identify new therapeutic targets.
- Preclinical trials using these models can accelerate the development of novel glioma treatments.
